In aesthetic practice, it is often incorporated into mesotherapy protocols and skin-support programs, where vitamin-based injectable solutions are used to complement broader treatment strategies focused on skin quality and metabolic support
It highlights the importance of publishing negative data.'' Further, biotechnology company Phosphagenics, which used the drug in an anti-cellulite cream BodyShaper, sold in major stores, revealed this week that it dumped the ingredient last November after 17 months because it was useless and incredibly expensive
In a notable phase II clinical trial published in The Lancet (2008), Tesofensine demonstrated dose-dependent weight loss of up to 10.6% over 24 weeks in obese individualssubstantially higher than placebo or many existing weight-loss drugs
It is not approved for human or veterinary use
So, what is the most common treatment for B12 deficiency